Browsing: Sciences

Life sciences and healthcare companies – from pharmaceutical manufacturers and medical device makers to hospitals, care providers and digital health platforms – face a rapidly evolving cyber regulatory landscape across the EU and UK.

This is a paid press release. Contact the press release distributor directly with any enquiries.

The six-nominee board challenge remains pending; a September 24 vote could change Anavex’s board, but no governance change is disclosed yet.

Aug. 18, 2026 /PRNewswire/ — J.P. Morgan Life Sciences Private Capital, the life sciences venture and growth equity arm within J.P. Morgan Asset Management, today announced the appointment of Bruce N. Rogers, Ph.D., as Venture Partner. Dr. Rogers will leverage his extensive background in medicinal chemistry, translational science, neuroscience, and immunology to develop and scale…

Manitoba’s largest hospital is still working to recover from a cyberattack a week after first discovering it.

Health Sciences Centre Winnipeg is investigating a ransomware incident affecting certain facility maintenance systems, including HVAC and door access. 

Procurement Sciences, an AI growth platform built for government contractors, announced it has acquired Rogue AI, an AI-native company focused on proposal and workflow automation for the government contracting industry. The deal is aimed at accelerating Procurement Sciences’ strategy to deliver a comprehensive, end-to-end AI platform that supports contractors across the full government contracting lifecycle.

Pharmaceutical and life sciences companies are investing heavily in customer relationship management (CRM) modernization and artificial intelligence, and for good reason. While CRM systems change is required, many organizations are embracing this opportunity to address the performance gap of today’s customer engagement model: